erythroferrone modulators (Silarus Therapeutics)

N/A

Report date: 2025/03/18 18:17:44
NME

Base Information

Drug Nameerythroferrone modulators (Silarus Therapeutics)
Drug Alias Nameerythroferrone modulators (UCLA)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepcidin modulators
TargetsHepcidin
Therapy Area/IndicationsIron OverloadAnemia, Iron-Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesSilarus Therapeutics Inc
Inactive CompaniesUniversity Of California, Los Angeles
Active IndicationsIron OverloadAnemia, Iron-Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A